|
Volumn 7, Issue 7, 2002, Pages 577-583
|
Sulphadoxine/pyrimethamine: An appropriate first-line alternative for the treatment of uncomplicated falciparum malaria in Ghanaian children under 5 years of age
a a a a a |
Author keywords
Children; Chloroquine; Drug resistance; Ghana; Malaria; Randomized trial; Sulphadoxine pyrimethamine; Treatment policy
|
Indexed keywords
CHLOROQUINE;
FANSIDAR;
CHILD HEALTH;
DISEASE TREATMENT;
DRUG RESISTANCE;
MALARIA;
ANTIBIOTIC RESISTANCE;
ARTICLE;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DRUG RESPONSE;
DRUG SCREENING;
DRUG SENSITIVITY;
FEMALE;
GHANA;
HEMATOLOGY;
HUMAN;
IN VIVO STUDY;
INFANT;
MAJOR CLINICAL STUDY;
MALARIA FALCIPARUM;
MALE;
OUTPATIENT DEPARTMENT;
PLASMODIUM FALCIPARUM;
POLICY;
PRESCHOOL CHILD;
RANDOMIZATION;
RANDOMIZED CONTROLLED TRIAL;
TREATMENT FAILURE;
WORLD HEALTH ORGANIZATION;
ANTIMALARIALS;
CHILD, PRESCHOOL;
CHLOROQUINE;
DRUG COMBINATIONS;
DRUG RESISTANCE;
FEMALE;
FOLLOW-UP STUDIES;
GHANA;
HUMANS;
INFANT;
MALARIA, FALCIPARUM;
MALE;
OUTPATIENTS;
PYRIMETHAMINE;
SULFADOXINE;
TREATMENT FAILURE;
TREATMENT OUTCOME;
GHANA;
PLASMODIUM FALCIPARUM;
PROTOZOA;
|
EID: 0036305510
PISSN: 13602276
EISSN: None
Source Type: Journal
DOI: 10.1046/j.1365-3156.2002.00910.x Document Type: Article |
Times cited : (14)
|
References (24)
|